Article

AMO completes acquisition of IntraLase

Santa Ana, CA-Advanced Medical Optics Inc. (AMO) has completed its acquisition of IntraLase Corp.

Santa Ana, CA

-Advanced Medical Optics Inc. (AMO) has completed its acquisition of IntraLase Corp.

AMO announced its intention to acquire IntraLase for $808 million in January. IntraLase stockholders approved the deal March 30, and the takeover was finalized April 2. Under the terms of the agreement, AMO paid $25 in cash per share of IntraLase stock and the individually determined cash value per share of outstanding stock options.

“The addition of IntraLase’s state-of-the-art femtosecond laser technology to AMO’s unmatched portfolio of corneal and cataract products allows us to forge a new path for vision care with a full suite of technologies to address a lifetime of refractive needs,” said Jim Mazzo, AMO chairman, president and chief executive officer. He also noted the company’s recently announced acquisition of WaveFront Sciences, developer and manufacturer of a high-resolution aberrometer.

AMO said it intends to leverage the large installed bases of AMO and IntraLase and combined international expansion strategies to establish AMO’s position further as the industry leader in laser diagnostics, flap-creation, and ablation technologies. The acquisition of Intralase also gives AMO entry into the corneal transplant market with the IntraLase-enabled keratoplasty technology.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.